Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 668.00 | |
50 mg | 10-14 weeks | $ 868.00 | |
100 mg | 10-14 weeks | $ 1,310.00 |
Description | Ruboxistaurin is a PKC beta inhibitor. Ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways. Ruboxistaurin inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. |
Synonyms | LY-333531, LY333531, LY 333531, LY-333531 Mesylate |
Molecular Weight | 564.65 |
Formula | C29H32N4O6S |
CAS No. | 192050-59-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ruboxistaurin mesylate 192050-59-2 LY333531 Mesylate LY-333531 LY333531 LY 333531 LY 333531 Mesylate Ruboxistaurin Mesylate LY-333531 Mesylate inhibitor inhibit